Legal & Regulatory

Ukraine: President Zelensky Signs Law Legalizing Medical Cannabis

Ukraine President, Volodymyr Zelensky, has signed a law legalizing medical cannabis to support citizens and soldiers with severe illnesses and PTSD, amidst the ongoing conflict with Russia. The reform includes reclassification of cannabis, establishment of regulations for medical use, and exploration of psychedelic therapies, positioning Ukraine at the forefront of innovative medical treatments.

In response to the growing medical needs caused by the ongoing conflict with Russia, Ukraine has taken a decisive step toward supporting its citizens, including soldiers affected by war traumas. President Volodymyr Zelensky officially signed a law legalizing the use of cannabis for medical purposes. This historic event, initiated on Wednesday, paves the way for new treatment methods for people suffering from severe illnesses and post-traumatic stress disorder (PTSD).

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

A Long Road to Medical Cannabis Legalization in Ukraine

The decision to legalize cannabis for medical purposes was preceded by months of intense discussions and attempts at blockades by the opposition. Eventually, after a failed attempt to overthrow the reform in parliament, the law was approved, marking a victory for the Zelensky government and patients waiting for alternative treatment methods.

The law will come into effect six months after its official publication, giving the government time to develop specific regulations governing the new program. The Ministry of Health and the Cabinet of Ministers of Ukraine are tasked with creating a solid foundation for the safe and effective implementation of medical cannabis in the healthcare system.

Changes in the Ukraine Drug Code

A key element of the reform is the reclassification of cannabis in the country’s drug code. Moving cannabis from the list of strictly prohibited substances (List I) to the list of substances allowed for medical use on prescription (List II) enables the start of importing cannabis products and developing domestic drug production based on it.

The law legalizes the use of medical cannabis for people struggling with severe diseases, including cancer, and PTSD, a direct result of ongoing war actions. Although the original text of the law specifically listed these two groups, the expansion of the catalog of diseases, including Alzheimer’s disease and epilepsy, reflects the lawmakers’ openness to the needs of patients with various ailments.

Regulations and Oversight

The responsibility for regulations concerning the cultivation and processing of cannabis will be entrusted to the Ministry of Agrarian Policy. Oversight of the distribution of medical cannabis will be a joint task of the National Police and the State Agency for Drugs, ensuring a high level of safety and control over the process of introducing medical cannabis for use.

President Zelensky, expressing his support for legalization, emphasized the importance of applying the best global practices and solutions to alleviate the suffering of Ukrainian citizens. His involvement in the legislative process and call for fair treatment of patients in need of cannabis-based medicines is an important element in the national debate on health and treatment.

Beyond Medical Cannabis

Ukraine is not only expanding its approach to mental health treatment using medical cannabis but is also exploring therapies using psychedelic drugs such as ketamine and MDMA. According to PsyloNews.pl, military units struggling with war traumas may benefit from psychedelic therapy.

Dr. Vladislav Matrenitsky, a pioneer in this field, has noted successes in treating patients suffering from PTSD and depression with ketamine, paving the way for further research and potential use of MDMA and psilocybin, despite current legal restrictions. There is hope for the approval of a pilot project using psychedelic substances, which could make Ukraine a leader in the global psychedelic therapy revolution, offering new hope for those affected by the conflict and its psychological effects.

The legalization of medical cannabis and the possibility of benefiting from psychedelic therapy in Ukraine is a groundbreaking moment that has the potential to change the lives of many patients. This decision, in addition to medical aspects, carries an important political and social message, highlighting the country’s openness to modern solutions in the field of medicine and patient care. In the face of ongoing conflict, this initiative is also a statement of striving to improve the quality of life of those affected by the consequences of war.

(Featured image by The Presidential Office of Ukraine (CC BY-NC-ND 4.0))

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Andrew Ross

Andrew Ross is a features writer whose stories are centered on emerging economies and fast-growing companies. His articles often look at trade policies and practices, geopolitics, mining and commodities, as well as the exciting world of technology. He also covers industries that have piqued the interest of the stock market, such as cryptocurrency and cannabis. He is a certified gadget enthusiast.

Recent Posts

2023 Sales of Legal Cannabis in the USA Generated Over $20bn In Taxes

Based on 2023 sales, the United States saw a record high in tax revenues from…

17 hours ago

One in Four French Prisoners Smokes Cannabis Daily

A study by the French Observatory of Drugs and Addictions reveals that one in four…

2 days ago

The Fall of an Icon: High Times and the Inevitable Auction of the Iconic Cannabis Brand

High Times, once a leading cannabis culture magazine, faces severe financial troubles, prompting a potential…

3 days ago

DEA Agrees to Reclassify Cannabis as a “Less Dangerous” Substance

The DEA plans to reclassify cannabis from Schedule I to Schedule III of the Controlled…

4 days ago

Pillar 2 Cannabis Pilot Program to Launch in Germany

Germany is advancing its cannabis policy by launching Pillar 2, which involves five-year pilot projects…

1 week ago

Rolling Papers May Contain Traces of Heavy Metals, Study Finds

A new study has revealed that rolling papers can contain heavy metals and chemical residues…

1 week ago